Page last updated: 2024-10-24

verapamil and Degenerative Disc Disease

verapamil has been researched along with Degenerative Disc Disease in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Y1
Cao, X1
Pan, B1
Du, H1
Li, B1
Yang, X1
Chen, X1
Wang, X1
Zhou, T1
Qin, A1
Zhao, C1
Zhao, J1

Other Studies

1 other study available for verapamil and Degenerative Disc Disease

ArticleYear
Verapamil attenuates intervertebral disc degeneration by suppressing ROS overproduction and pyroptosis via targeting the Nrf2/TXNIP/NLRP3 axis in four-week puncture-induced rat models both in vivo and in vitro.
    International immunopharmacology, 2023, Volume: 123

    Topics: Animals; Carrier Proteins; Cell Cycle Proteins; Humans; Inflammasomes; Intervertebral Disc; Interver

2023